IM Cannabis : Management's Discussion and Analysis Q2 2023
IM Cannabis Corp. Management's Discussion and Analysis For the Three and Six Months Ended June 30, 2023 August 14,... -Today at 10:29 am- MarketScreener
Stay updated with breaking news from Vironna Pharm. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
IM Cannabis Corp. Management's Discussion and Analysis For the Three and Six Months Ended June 30, 2023 August 14,... -Today at 10:29 am- MarketScreener
Company to continue its focus on the Israeli and German markets with a primary goal of sustainably increasing revenue in each of these core markets and accelerating path to profitability, while actively
/PRNewswire/ -- IM Cannabis Corp. (the "Company" or "IMC") (NASDAQ: IMCC) (CSE: IMCC), an international medical cannabis company, today announced its financial...
IM Cannabis Reports Record First Quarter 2022 Financial Results; Revenues Increase 169% YoY to $23.6 Million. Gross Profit Increased 37% from Q1 2021 as Operational... #imcannabis #IMCHoldings #imcc
IM Cannabis Corp. Appoints Rinat Efrima as New Chief Executive Officer of IMC Holdings, the Company’s Israeli Subsidiary. Oren Shuster remains Chief Executive Officer and... #imcannabis #imc #imcc